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• Computational approaches are becoming an essen-
tial tool in modern drug design and discovery
• Automated workflows from triaging via docking
to molecular dynamics (MD) approaches are being
actively developed for drug discovery in a virtual
hit-to-lead sprit.
• Reliable determination of absolute binding free en-
ergy (ABFE) via MD on HPC system is key re-
quirement for virtual screening in industrial and
academic settings
• Free energy perturbation methods (FEP) for ABFE
of drug-receptor systems are plagued by uncertain-
tis related to sampling and protocols,
• The HPC-tailored nonequilibrium approach, com-
bining multiple enhance sampling simulations with
fast-swicthing alchemical methods, can deliver ac-
curate estimates and credible confidence intervals
for ABFE
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Abstract
Computational approaches are becoming an essential tool in modern drug design and discovery, with fast compound
triaging using a combination of machine learning and docking techniques followed by molecular dynamics binding
free energies assessment using alchemical techniques. The traditional MD-based alchemical free energy perturbation
(FEP) method faces severe sampling issues that may limits its reliability in automated workflows. Here we review
the major sources of uncertainty in FEP protocols for drug discovery, showing how the sampling problem can be
effectively tackled by switching to nonequilibrium alchemical techniques.
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1. Introduction
Molecular dynamics-based (MD) techniques using
state of the art force fields such as AMBER/GAFF[1],
CHARMM/CgenFF[2] and OPLS,[3], are considered as
an essential and powerful tool for reliably predicting
binding free energies in drug-receptor systems. In drug
discovery projects, due to the high computational de-
mand, MD methods are being increasingly used[4, 5, 6]
in a post-docking refinement stage, via the implementa-
tion of partially automated virtual screening workflows
in a hit-to-lead spirit.
In the last decades, MD methodologies have been
devised for solvation and binding free energy calcula-
tions, with the so-called alchemical route emerging as
one of the most powerful approaches.[5] Alchemical
approaches, in essence, evaluates the absolute binding
free energy (ABFE) as the difference of the solvation
energy of the ligand in the bound state and in the bulk.
These solvation energies, in turn, are computed by pro-
gressively decoupling the ligand from the environment,
either along a stratification[7] of discrete equilibrium
intermediate λ-states using free energy perturbation[8]
(FEP) or, equivalently, thermodynamic integration[9]
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(TI), or by varying continuously the λ coupling alchem-
ical parameter in a swarm of fast independent and con-
current trajectories, exploiting the Jarzynski[10] and
Crooks[11] theorems on the resulting nonequilibrium
work (NEW) distribution.
Most of the drug discovery alchemical applications,
paralleling the medicinal chemistry practice, deal with
the calculations (via FEP[12, 13, 6, 14, 15] or NEW[16,
17]) of relative binding free energies (RBFE), evaluat-
ing the free energy cost of transmuting a ligand into a
strictly congeneric compound, a process involving, in
general, a relatively small (few kcal/mol) perturbation.
On the other hand, as recently noted[5], efficient ABFE
approaches are urgently needed in the implementation
of virtual screening funnel workflows from docking-
based triaging to MD-based methodologies.[18] Dock-
ing campaigns on large compounds databases may in
fact produce chemically distant hits that are not easily
amenable for RBFE calculations.
Despite the last decades progresses, FEP-based
ABFE for drug design still constitutes an awesome chal-
lenge as these methodologies involve large perturba-
tions (tens of kcal mol) facing hurdles and entangle-
ments related to the need for equilibrium sampling on
each λ-state of the discrete alchemical stratification. As
acutely pointed out in Ref. [19], at low coupling, al-
chemical simulations experience order-disorder transi-
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tions to entropically favored states where the weakly
coupled ligand can freely rotate and translate within the
binding site region as opposed to the ordered high en-
thalpy states observed at the full coupling. These order-
disorder transitions cause entropic bottlenecks which
hinder the equilibration and convergence of binding free
energy estimates. These entanglements are commonly
bypassed by enforcing a set of restraint potentials[20]
limiting the conformational activity of the ligand and
hence the need for extensive sampling, shifting de facto
the “sampling issue”[21] to the highly non trivial eval-
uation of the free energy cost of imposing and releasing
those restraints[4, 22].
Quite curiously, in the authoritative perspective paper
by Cournia and coworkers,[5] while FEP methodologies
are amply and critically discussed, nonequilibrium (NE)
alchemical techniques are not even mentioned, despite
their recent success in the recent SAMPL rounds,[23,
24] as well in retrospective applications[25, 26]. In the
SAMPLing challenge,[24], in particular, where a va-
riety of methodologies were systematically compared
for ABFE predictions, a NEW-based approach, the
nonequilibrium switch double system single box (NS-
DSSB),[27] remarkably obtained the overall highest ef-
ficiency and accuracy in the CB8-quinine system where
both the host and the guest exhibited long correlation
times and sampling challenges.
In the present contribution, we will review the FEP
and NEW alchemical approach concerning the crucial
and undervalued aspect of the reproducibility of the
ABFE and of the determination of a credible confidence
interval, a quantity of no less importance of the predic-
tion itself, being strictly related to the investment risk in
industrial drug discovery projects. We shall focus here
on the statistical uncertainty deriving from the method-
ological and computational protocol, disregarding the
systematic errors that may arise from force field defi-
ciencies, a matter that is the object of a continuous and
intense specialistic research.[28, 29, 30]
2. Uncertainties in alchemical FEP methodologies
In modern FEP applications, the bound and unbound
ligand decoupling (solvation) free energies are com-
puted as a sum of the n − 1 individual free energy con-










where Pi(∆V i+1i ) = 〈δ(∆V − (Vi+1(x) − Vi(x))〉i,
Pi+1(∆V ii+1) = 〈δ(∆V − (Vi(x) − Vi+1(x))〉i+1 are the
distributions of the potential energy difference between
thermodynamic states with the alchemical parameters
λi+1 and λi and 〈·〉i,〈·〉i+1 indicate canonical averages
using the λi and λi+1 Hamiltonian, respectively. E(·)
is a functional representing the estimate of the loga-
rithm of the ratio two contiguous partition functions,
∆Gi+1i = kBT ln Zi/Zi+1.[31]
E(·) corresponds, in the vast majority of FEP appli-
cations, to the Bennett Acceptance Ratio (BAR)[32, 33]
BAR provides an accurate and precise estimate for the
individual ∆Gi+1i , so long that the contiguous poten-
tial energy distributions Pi(∆V i+1i ) and Pi+1(−∆V
i
i+1) do
have a significant overlap. The λ protocol (i.e. the num-
ber and spacing of the λ states) should be chosen to
yield a significant and approximately constant overlap
along the alchemical stratification, to correspondingly
make the uncertainty on each of the n−1 ∆Gi+1i approxi-
mately constant, minimizing the overall uncertainty.[34]
∆Gi+1i could be also computed as a functional of all
the forward and reverse n − 1 energy distributions, an
estimator known as multiple Bennett Acceptance ratio
(MBAR),[35] yielding however an only marginal in-
crease in precision and accuracy.[31, 36, 37, 14]
Ultimately, the FEP dissociation free energy estimate
is given by
∆G′d = ∆Gb − ∆Gu (3)
where the suffix b, u refers to the bound and unbound
state for the ligand and where ∆Gb,∆Gu are computed
according to Eqs. 1, 2. The prime indicates that the
dissociation free energy must be corrected by a stan-
dard state dependent term related to the binding site
volume.[38, 39] We will return on this subtle point later
on in this section.
Given a mean to compute the individual uncertain-
ties δ∆Gi+1i , the overall uncertainty of the estimate
can be obtained by summing in quadrature the errors
along the bound and unbound alchemical stratifica-
tion. In most FEP calculations, individual uncertainty,
δ∆Gi+1i , are evaluated either by computing the variance
on block averages or by bootstrapping techniques.[7]
This is accomplished usually by way of black-box
post-processing application scripts (e.g. gmx bar in
gromacs[40] or pymbar[35] for AMBER[1] ). Sum-
mation of the errors in quadrature is based on the tacit
assumption that repeated calculations of the individual
∆Gi+1i yield n-1 independent and normally distributed
random variables (RV).
Actually, repeating a FEP computation for a com-
plex drug-receptor system, starting, e.g., from differ-
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ently prepared initial conditions or using a slightly dif-
ferent FEP protocol, may often produce a free energy
estimate that differs from the original by a quantity
largely exceeding the uncertainty evaluated using the
data of a single FEP simulation.[36, 41, 42, 14] This is
due to the way canonical (ensemble) averages, Ā = 〈A〉,
are estimated as time averages Ā = 1
τ
∫ τ
0 A(t)dt, in the
assumption that ergodicity holds in the time τ, or stated
in other terms, that the sampling with respect to all rel-
evant coordinates is canonical in the time τ.
In the practice of FEP applications, τ is generally and
arbitrarily chosen equal for all λ states in a range from
few to few tens of nanoseconds, while convergence rates
may differ substantially with different ligand coupling.
[43, 44, 19] Side chains conformational motions, on the
other hand, are observed in NMR experiments on a mi-
crosecond time range.[45] A simple movement such as
the DFG flip, marking the active and inactive state in the
apo state of kinases, is believed to occur on a millisec-
ond time scale,[46] which means that just one sudden
DFG flip per millisecond is observed on the average in
a single molecule. Paradoxically, the advent of GPUs
in scientific calculations, that allows simulating a typi-
cal drug-receptor system for up to hundreds ns/day, has
strengthened the illusion that a single sufficiently long
MD trajectory can achieve correct sampling in FEP ap-
plications of complex biomolecular systems.
More than two decades ago, it was authoritatively[48]
recognized that “individual trajectories of length up to 5
ns [at that time, 5 ns sounded like an eternity] sample
only a fraction of the conformational distribution gen-
erated by ten independent 120 ps trajectories at 300 K”.
This fact can be understood using the ball maze vintage
game metaphor (see Figure 1). The holes in the board
are akin to attractors (e.g. conformational states) in a
protein system. While many short trajectories started
from infinitesimally different initial conditions can sam-
ple several attractors like an ejected ball from the same
spot can end up each time in a different hole, a single tra-
jectory may get stuck in one of the attractors for a long
time before it can jump to a different conformational
states. Stated in other terms, staring at just one molecule
in the hope of observing a rare event (e.g. a conforma-
tional transition) while such event is occurring in many
of the molecules of the thermodynamic ensemble right
behind the observer, is a rather tenuous approach. As a
result, “one-off” FEP simulations are in general poorly
reproducible.[49, 50]
These concepts have been recently formalized in
terms of ergodicity, sensitivity to initial conditions of
deterministic iterators[51], equilibrium and chaos in
Hamiltonian systems[42] and discussed in a series of
Figure 1: Upper panels: vintage ball maze gameboard (left) and hy-
pothetical 2D free energy surface of a complex system with different
attractors (metastable free energy minima). Lower panel: 2D free
energy surface (FES) obtained for the two indicated dihedral angles
marking the gauche (|θ|, |φ| ≤ 60◦), anti (120◦ ≤ |θ|, |φ| ≤ 180◦) states
of a synthetic precursor of kinase inhibitors (taken from the SAMPL6
challenge[47]) in water in standard conditions ; on the left, the 2D-
FES computed using 8 batteries of HREM simulations (with eight
replicas each) lasting 1 ns (for a total of 64 ns); on the right the same
surface as obtained by the sampling of one single standard MD sim-
ulation in 64 ns. While the 1 ns HREM simulations effectively sam-
pled all 4 conformational attractors in SM02, the standard MD, was
incapable of sampling the gauche-gauche and gauche-anti attractors
in 0.06 µs of simulation.[44]
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remarkable papers on MD applications for drug de-
sign by Coveney and coworkers[42, 49, 37] In Ref.
[37], in particular, the uncertainty of FEP-determined
ABFE for some BRD4, FGFR1 and thrombin com-
plexes was quantified and assessed using various en-
hanced sampling approaches, including multiplets of λ-
hopping Hamiltonian replica exchange (HREM) simu-
lations with solute tempering (REST)[52] at intermedi-
ate λ’s (a methodology also known as FEP+)[53, 15]
and multiplets of REST for each λ states. In REST, the
“heating” via energy scaling (and hence kinetic boost-
ing) is limited to the so-called[12] “hot zone” including
the ligand and the nearby residues. Despite the tremen-
dous CPU time invested, results for the ABFE were still
affected by large and highly system-dependent uncer-
tainties evaluated using random combinations of mul-
tiple simulations that were found to “vary by as much
as 2.6, 6.5, and 7.6 kcal/mol for BRD4, FGFR1, and
thrombin”.
Some remarks are in order on the calculation of the
standard state volume term, that when added to Eq. 3,
should yield the standard dissociation energy. In the
FEP practice, such term is estimated from the differ-
ence between the free energy of imposing a restraint
potential (usually a harmonic function involving trans-
lational, orientational and conformational degrees of
freedom of the ligand[20]) in the binding site at the
full ligand coupling, minus the free energy of releas-
ing that restraint at zero coupling (or viceversa). These
restraints are introduced to alleviate the sampling is-
sues characterizing flexible ligands and protein side
chains.[4] In the strong restraint limit, the contribu-
tion of the translational restraint can be shown[39, 54]
to be equal to RT ln(Vsite/V0) (where Vsite is the al-
lowance volume of the ligand in the binding pocket)
constituting a penalty for the dissociation free energy,
∆G0 = ∆G′ + RT ln(Vsite/V0), so long that Vsite < V0,
with V0 = 1661 Å3 being the standard state volume.
While the zero-coupling restraint contribution is com-
puted analytically, the free energy cost of the restraints
at full coupling in virtually all FEP applications for
ABFE determination is inappropriately computed again
via an FEP-like approach where the restraints are pro-
gressively switched on (or off), in few windows and in
few tens of ns in total at best, with the ligand lingering
in the presumed binding site with the presumed confor-
mation/orientation. Needless to say that if the presump-
tions were wrong, the prediction is also wrong. Besides,
with no or very weak restraint potential (i.e. in the
first strata of the FEP-restraint approach) for the fully
coupled ligand in the bound state, a true equilibrium
sampling would directly allow the estimate the bind-
ing affinity by simply evaluating the probability ratio of
the bound and unbound states.[55] A more sensible ap-
proach of this questionable FEP-restraint computational
practice has been recently proposed by Heinzelmann
and Gilson[4] where the authors evaluated the binding
free energies ∆Gi for multiple ligand-receptor poses (i.e.
with no assumption on the “best” ligand pose), recover-
ing the free energy as ∆G = −RT ln(
∑
i e−β∆Gi ).
3. NEW-based approach for ABFE calculations
In NEW-based techniques, the connection between
the end-states is performed by a swarm of fast non-
equilibrium trajectories rather than by a stratification of
equilibrium λ states. These λ-driven NE trajectories are
started from a canonical (equilibrium) sampling of one
end-state ending up in nonequilibrium configurations of
the other end-state. As such, at variance with FEP, the
sense of the transformation is important in NEW, that
is, the distributions of the work values (that are related
to the free energy via the Jarzynski or Cooks theorems)
can be markedly different performing the process in one
sense or the other.
In this respect, it has been shown[31, 24] that when-
ever the NE transformation involves the entrance into or
escape from a free energy funnel (such as the folding
of a protein or the formation of a drug-receptor com-
plex), the process is much less dissipative in the escape
direction. The dissipation is defined as the difference
between the mean NE work done in the independent
driven processes and the underlying free energy. If the
induced-fit upon binding involves important conforma-
tional reorganization in the protein pocket, recoupling a
ghost ligand starting from the equilibrium apo state of a
protein via fast (few hundreds picoseconds) NE trajec-
tories can be a tremendously dissipative process, with
a high probability of producing a manifold of subop-
timal NE poses characterized by negligible Boltzmann
weight. In the escape direction, the fast NE decoupling
of a well fit bound ligand, yields, in general, less dissi-
pation as the NE end-states (free protein and gas-phase
ligand) involve no mutual conformational clashes.
In NEW, the alchemical free energies are a func-
tional of the work distributions and the uncertainty is
strictly related to the dissipation of the process, pro-
portional to the inverse of the duration time τ of the
NE trajectories[56]. For normal work distributions, it
can be shown[57, 16, 36, 25] that the leading term of
the uncertainty in the NEW estimates, is proportional
to σ2/(kBTn1/2) where n is the number of collected NE
work values and σ2 is the variance of the work distribu-
tion.
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While the unbound state leg of the NEW alchemi-
cal thermodynamic cycle can be performed in either di-
rection or both using bidirectional estimators such as
BAR, the bound state leg should be performed in the
less dissipative annihilation direction, unless imposing
restraints that would imply, as we have discussed previ-
ously, strong (and possibly wrong) assumptions on the
binding poses.
The NEW thermodynamic cycle can be effectively
unified[58] in a protocol whereby the ligand undergoes
nb fast-annihilation and nu fast-growth in the bound
state and in the bulk, respectively, implementing a sort
of “virtual” DSSB approach.[27] The resulting indepen-
dent nu and nb-sized work histograms, Pu(W), PB(W),
are then convoluted to yield a statistically boosted work
histogram (PB ∗ Pu)(W) constructed using nu × nb in-
dependent values W = Wb + Wu, lowering the un-




are illustrated in Figure 2. The standard state correc-
tion in NEW is implemented by estimating the trans-
lational volume Vsite from the fluctuation of the COM-
COM distance[59]. As pointed out in Ref. [59], such
correction can be a source of uncertainty, partially mit-
igated by the logarithmic dependency of the volume ra-
tio. We recall that binding site volume determination is
the rather undervalued weak point of any computational
approach based on the definition of “bound state”, in-
cluding of course FEP-based techniques for ABFE and
RBFE, as well. The latter implicitly (and arbitrarily) as-
sume the constancy of the binding site volume upon the
transmutation of the bound ligand into another bound
parent compound.
4. Conclusion
There are several aspects in favor of the NEW al-
chemical approach for ABFE in drug design. In NEW,
the equilibrium sampling is required only for the end-
states and such sampling can be effectively obtained,
as we have seen (see Figure 1), using batteries of
concurrent relatively short enhanced sampling simula-
tions, an algorithm that is perfectly tailored for mod-
ern homogeneous or heterogeneous parallel computing
(HPC) platforms. Such enhanced sampling of the end-
state in the bound state can be performed by “heating”
along the HREM progression all atoms in the binding
site (REST), imposing a weak harmonic restraint be-
tween the centers of mass (COM) of the fully coupled
ligand and the receptor and hence allowing an unre-
strained sampling of the conformational/orientational
states of the bound ligand and nearby residues. The
end-states of the unbound state can be generated essen-
tially at no cost by performing multiplets of HREM on
an isolated (gas-phase) molecule and combining the so
sampled gas-phase states of the ghost ligand with pre-
equilibrated samples of the solvent. The second step in
NEW corresponds to the embarrassingly parallel pro-
duction of NE decoupling/recoupling alchemical trajec-
tories, again a computation that can be efficiently imple-
mented on an HPC platform. Given that the sampling
of the end-states is accurate, accuracy and precision in
NEW-based ABFE estimates depend only on the dis-
sipation and on the resolution of the convoluted work
histogram (PB ∗ Pu)(W). This is strikingly at variance
with FEP techniques, where accuracy and precision are
an unknown function of the energy distributions in all λ
windows, de facto preventing a reliable estimate of the
confidence interval of the prediction in “one-off” calcu-
lations.
NEW efficiency, accuracy, and precision has been
amply assessed in recent studies.[36, 56, 60, 16, 17]
Besides producing accurate and reproducible results
for solvation energies[36, 61], RBFE[16, 17] and
ABFE[59] estimates, NEW provides by design a cred-
ible methodological confidence interval, a fundamental
quantity in an industrial setting. Despite these features,
and despite its consistently good performances in recent
blind challenges for ABFE predictions[24, 62], NEW is
still scantly used compared to FEP-based approaches,
both in academic and pharmaceutical contexts. Popular
MD engines, such as gromacs, AMBER or OpenMM,
already support HREM and fast switching alchemical
schemes, the two key ingredients in NEW. What is prob-
ably deterring end-users in selecting NEW for ABFE
and RBFE calculations is the lack of software tools for
the complex pre- and post-processing of the two com-
putational steps in NEW, namely the preparation of the
enhanced sampling of the equilibrium end-states and the
manipulation of the work data resulting from the fast-
switching stage. Such tools, such as pmx[63] (gromacs)
or BAT.py[4] (AMBER) or Flare[6] (OpenMM) have
been recently developed and tailored for FEP-based al-
chemical applications and could be easily adapted for
NEW alchemy as well.
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Figure 2: Virtual DSSB workflow in NEW. Enhanced sampling of the a) unbound state and of the b) bound state (the “hot zone in HREM is
highlighted in the orange spheres). c) Volume COM-COM fluctuations in the bound state HREM. d) NE recoupling (unbound) and decoupling
(bound) runs yielding the Pu(W), Pb(W) work histograms. e) (PB ∗ Pu)(W) convolution process. f) calculation of the standard dissociation free
energy using Vsite and (PB ∗ Pu)(W). Confidence interval is computed by bootstrapping on the Wu and Wb collection prior to convolution.
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